MHLW installs new research team on safety assessment of iPS differentiated cells.

The team is under guidance of Tsugiya FUKUI and the objectives are to quantitatively assessing the risk of iPS cell-derived differentiated cells after transplantation

Nikkei Biotech news release, November 20, 2015

MHLW installs new research team on safety assessment of iPS differentiated cells.
Scroll to top